Overview
- 32 inspections across 31 sites are on record.
- 5 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-12.
At a glance
Inspections
32
Sites
31
Observations
5
Career since
Aug 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| TRS Labs, Inc. | 12 May 2026 | Animal Drugs & Feeds | View 483 → |
| Jiangsu Center for Safety Evaluation of Drugs | 3 Apr 2026 | Human Drugs | On file |
| Hubei Topgene Xinsheng Biotechnology Co., Ltd. | 27 Mar 2026 | Human Drugs | |
| John (NMI) Nguyen, MD | 11 Feb 2026 | Human Drugs | |
| Rachel L. Mitchell, M.D. | 18 Dec 2025 | Human Drugs |
Sites inspected
TRS Labs, Inc.Athens, United States1 insp.
Jiangsu Center for Safety Evaluation of DrugsNanjing, China1 insp.
Hubei Topgene Xinsheng Biotechnology Co., Ltd.Wuhan, China1 insp.
John (NMI) Nguyen, MDMorgantown, United States1 insp.
Rachel L. Mitchell, M.D.Nashville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Laura L Staples5 shared
Mark J Seaton2 shared
Zhou Chen2 shared
Carmen Y Fisher2 shared
Matthew R Coleman2 shared
Brittany L Carpenter1 shared
Kellie R Riggs1 shared
Ann B Borromeo1 shared
Christopher M Jeffers1 shared
Sheri L Stephenson1 shared
Full investigator report
Get the verbatim findings behind Marshall A Naimo's 5 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site